Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study

Anemia is an inevitable complication of hemodialysis, and the primary cause is erythropoietin deficiency. After diagnosis, treatment begins with an erythropoiesis-stimulating agent (ESA). However, some patients remain anemic even after receiving this medication. This study aimed to investigate the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, E.J.F., Hortegal, E.V., Serra, H.O., Lages, J.S., Salgado-Filho, N., dos Santos, A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972010/
https://www.ncbi.nlm.nih.gov/pubmed/29742267
http://dx.doi.org/10.1590/1414-431X20187288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972010/
https://www.ncbi.nlm.nih.gov/pubmed/29742267
http://dx.doi.org/10.1590/1414-431X20187288

Ejemplares similares